Symetis develops, produces and markets heart valve replacement solutions for the treatment of severe cardiac valve. The company plans to raise € 55.8 million that could be increased to approximately € 64.1 million in the event of full exercise of the Overallotment Option. It's already the third younger Swiss technology company going public this year.
Innovative biotech company TAmiRNA has entered a partnership agreement with SimplicityBio, the Swiss-based bioinformatics company and in silico biomarker discovery specialist. TAmiRNA is a biotech company specialized in the identification and validation of biomarkers for age-related diseases such as osteoporosis, cardiovascular disease, type-2 diabetes, and cancer.
GES, a global full-service provider for live events, announced the purchase of Poken, a cloud-based event management platform founded 2007 in Switzerland. Poken brings together digital and physical event spaces to drive engagement and gain better insight through real data. Investors of Poken included Swiccom, Redalpine, SVC and business angels.
More than 130 participants already registered for the Swiss Venture Day taking place on 5 April in Zurich. First one-to-one meetings have been booked and first start-ups are selected. Companies have until 25 March to apply.
Tradeplus24 hat zusammen mit seinen Partnern Kessler & Co und dem Versicherungskonzern AIG ein Angebot entwickelt, mit dem KMU ihre Debitoren zur Liquiditätsbeschaffung nutzen können. Nun hat das 2016 gestartete Fintech Startup eine Finanzierungsrunde abgeschlossen Leadinvestoren sind Dornonville de la Cour & Toggenburger.